Plasma P-tau181 as a Marker of Progression to Alzheimer’s Disease Dementia in Subjective Cognitive Decline and Mild Cognitive Impairment. (P10-3.010)
To explore the prognostic role of plasma phosphorylated tau (p-tau) 181 levels in Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI) as a marker of progression along the continuum of cognitive decline.
Authors
- Valentina Moschini
- Valentina Bessi (ORCID: https://orcid.org/0000-0002-6176-3584)
- Giulia Giacomucci (ORCID: https://orcid.org/0000-0002-8711-331X)
- Salvatore Mazzeo (ORCID: https://orcid.org/0000-0001-5985-5060)
- Sonia Padiglioni
- Benedetta Nacmias (ORCID: https://orcid.org/0000-0001-9338-9040)
- Silvia Bagnoli (ORCID: https://orcid.org/0000-0002-4373-6611)
- Carmen Morinelli
- Assunta Ingannato (ORCID: https://orcid.org/0000-0003-4955-0321)
- Chiara Crucitti
- Sandro Sorbi
Institutions
- Vita-Salute San Raffaele University (IT)
- Dementia UK (GB)
- University of Florence (IT)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208530
- Primary Topic
- Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00